2009
DOI: 10.1053/j.semperi.2009.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of Preterm Birth Based on Short Cervix: Progesterone

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0
2

Year Published

2013
2013
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 39 publications
0
10
0
2
Order By: Relevance
“…This approach has not been successful, as such interventions are usually performed too late in the process to succeed. A second problem with the current management of preterm labor is that only women who have clear risk factors (abnormally short cervixes) or a history of PTBs are targeted for interventions designed to prevent PTB (2630). The vast majority of PTBs occur in women who are considered low-risk because they are either on their first pregnancies or have only had term births previously (3137).…”
mentioning
confidence: 99%
“…This approach has not been successful, as such interventions are usually performed too late in the process to succeed. A second problem with the current management of preterm labor is that only women who have clear risk factors (abnormally short cervixes) or a history of PTBs are targeted for interventions designed to prevent PTB (2630). The vast majority of PTBs occur in women who are considered low-risk because they are either on their first pregnancies or have only had term births previously (3137).…”
mentioning
confidence: 99%
“…The exact systems by which a blockade of progesterone activity may prompt cervical changes are intricate and inadequately interpreted. A decrease in progesterone activity most likely causes cervical changes by the action of inflammatory mediators [16].…”
Section: Discussionmentioning
confidence: 99%
“…This study showed that preterm delivery decreased significantly with the administration of progestin. 25,26 Dodd et al performed a meta-analysis from 11 randomized clinical trials (RCT) about the use of intramuscular progestin 17 alpha-hydroxyprogesterone caproate (17 OHP-C) and four RCTs about the intravaginal use of natural microionized progesterone. This meta-analysis demonstrates that prevention of preterm delivery using both natural and synthetic progestin may decrease preterm delivery rate and low birth weight for babies in impending preterm delivery cases.…”
Section: Introductionmentioning
confidence: 99%
“…27 Other study suggests that women with single pregnancy, no history of preterm delivery and cervical length of ≤2 cm, who receive intravaginal progestin (gel) 90 mg or 200 mg suppositories, are related to the reduction of preterm delivery and perinatal morbidity and mortality. 25,[28][29][30][31][32] Natural progesterone administration has no side effects for the fetus growth and development, nor adding any risk for congenital anomaly. Northen et al stated that after 4 years of observation in 278 children whose mothers received long-term natural progesterone therapy during pregnancy, none had side-effects based on the physical examination, motoric and personal-social ability.…”
Section: Introductionmentioning
confidence: 99%